Pfizer Inc

NYSE: PFE
$26.72
-$0.32 (-1.2%)
Closing Price on November 8, 2024

PFE Articles

Cathie Wood's ARK Invest Sells Over 400,000 More Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds sold over 400,000 shares of Pfizer on November 11.
Chris Lange
Published:

Cathie Wood's ARK Invest Sells Over 140,000 More Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds sold over 140,000 shares of Pfizer on November 10.
Chris Lange
Published:

Cathie Wood's ARK Invest Sells Over 230,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds sold over 230,000 shares of Pfizer on November 9.
Chris Lange
Published:

Earnings Previews: BP, Pfizer, Under Armour
An oil and gas supermajor looking to transform its business, a Dow component and a struggling athletic gear company are reporting earnings before markets open Tuesday.
Paul Ausick
Published:

Cathie Wood's ARK Invest Buys Over 180,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds bought over 180,000 shares of Pfizer on September 7.
Chris Lange
Published:

Cathie Wood's ARK Invest Buys Over 380,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds bought over 380,000 shares of Pfizer on September 1.
Chris Lange
Published:

Cathie Wood's ARK Invest Buys Over 350,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds bought over 350,000 shares of Pfizer on August 27.
Chris Lange
Published:

Cathie Wood's ARK Invest Buys Over 170,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds bought over 170,000 shares of Pfizer on August 26.
Chris Lange
Published:

Cathie Wood's ARK Invest Buys Over 160,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds bought over 160,000 shares of Pfizer on August 23.
Chris Lange
Published:

Cathie Wood's ARK Invest Buys Over 150,000 Shares of This COVID-19 Vaccine Supplier
One of Cathie Wood's ARK Invest funds bought over 150,000 shares of Pfizer on August 18.
Chris Lange
Published:

Tuesday's Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, American Airlines, Chipotle, JD.com, Pfizer, Starbucks and More
Tuesday's top analyst upgrades and downgrades included AbbVie, Alibaba, American Airlines, AT&T, Chipotle Mexican Grill, JD.com, Kimberly-Clark, Pfizer, Starbucks and Weyerhaeuser.
Lee Jackson
Published:

Earnings Previews: Boeing, McDonald's, Pfizer, Tilray
Two Dow Jones industrial average components report quarterly earnings before markets open Wednesday, along with a cannabis company that gets some attention as a meme stock.
Paul Ausick
Published:

Thursday's Top Analysts Upgrades and Downgrades: Apple, Darden Restaurants, Peloton, Pfizer, Pioneer Natural Resources and More
Thursday's top analysts upgrades and downgrades included Apple, Darden Restaurants, Peloton, Pfizer, Pioneer Natural Resources, Tilray and Zynga.
Lee Jackson
Published:

Earnings Previews: CVS, Pfizer, Under Armour and More
Two alternative energy companies report March quarter earnings after the closing bell Monday, and three other noteworthy reports are due before Tuesday's opening bell.
Paul Ausick
Published:

Abercrombie, Pfizer, Teva and More of Wednesday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including Abercrombie & Fitch, Pfizer and Teva Pharmaceutical.
Chris Lange
Published: